| 中文名称: | 达沙替尼 |
| 中文别名: | 达沙替尼;N-(2-氯-6-甲基苯基)-2-[[6-[4-(2-羟乙基)哌嗪-1-基]-2-甲基嘧啶-4-基]氨基]-1,3-噻唑-5-甲酰胺;达沙替尼及其中间体;达沙替尼(无水);达沙替尼,Dasatinib;达沙替尼API;达沙替尼-D8;达沙替尼标准品;达沙替尼无水物;达沙替尼杂质;美喹他嗪;5-噻唑甲酰胺,N-(2-氯-6-甲基苯基)-2-[[6-[4-(2-羟基乙基)-1-哌嗪基]-2-甲基-4-嘧啶基]氨基];DASA锡IB;达沙替尼(无水)(对照品) |
| smiles: | O=C(C1=CN=C(S1)NC2=NC(C)=NC(N3CCN(CC3)CCO)=C2)NC4=C(C=CC=C4Cl)C |
| 英文名称: | Dasatinib |
| 英文别名: | DASATINIB;Dasatinib & its intermediates (R&D);Dasatinib & its intermediates;Dasatinib intermediate;5-Thiazolecarboxamide, N-(2-chloro-6-methylphenyl)-2-[[6-[4-(2-hydroxyethyl)-1-piperazinyl]-2-...;5-Thiazolecarboxamide, N-(2-chloro-6-methylphenyl)-2-[[6-[4-(2-hydroxyethyl)-1-piperazinyl]-2-methyl-4-pyrimidinyl]amino]-;Dasatinib (anhydrous);Dasatinib (BMS-354825,Sprycel®);Dasatinib anhydrous;BMS354825;BMS-354825;Dasatinib Tablets;SYR472;Trelagliptin succinate;N-(2-Chloro-6-methylphenyl)-2-[[6-[4-(2-hydroxyethyl)piperazin-1-yl]-2-methylpyrimidin-4-yl]amino]-1,3-thiazole-5-carboxamide;BMS 354825;Dasatinib;MFCD11046566;N-(2-chloro-6-methylphenyl)-2-(6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-ylamino)thiazole-5-carboxamide;FT-0650671;Dasatinib (BMS-354825);GTPL5678;CHEBI:49375;MLS006010904;BDBM13216;NCGC00181129-22;NCGC00181129-12;D5949;BMS 35482513;CAS-302962-49-8;DTXCID2020979;EX-A401;BCPP000263;NCGC00181129-03;AKOS015902363;NSC759877;Q-101345;5-Thiazolecarboxamide, N-(2-chloro-6-methylphenyl)-2-((6-(4-(2-hydroxyethyl)-1-piperazinyl)-2-methyl-4-pyrimidinyl)amino)-;HMS2043N05;NSC-800087;MLS003915609;HMS3265C19;CS-0100;SR-00000000554-5;BMS-354825-03;HMS3244A06;N-(2-chloro-6-methylphenyl)-2-[[6-[4-(2-hydroxyethyl)piperazin-1-yl]-2-methylpyrimidin-4-yl]amino]-1,3-thiazole-5-carboxamide;BMS 345825;C22H26ClN7O2S;NCGC00181129-14;NCGC00181129-01;DASATINIB [WHO-DD];BMS Dasatinib;DTXCID50157977;302962-49-8 pound not863127-77-9;N-(2-chloro-6-methyl-phenyl)-2-[[6-[4-(2-hydroxyethyl)piperazin-1-yl]-2-methyl-pyrimidin-4-yl]amino]thiazole-5-carboxamide;BRD-K49328571-001-07-7;DTXSID50235486;EN300-123025;DTXSID4040979;HY-10181;cid_3062316;NS00001968;anh. dasatinib;302962-49-8;ZBNZXTGUTAYRHI-UHFFFAOYSA-N;SCHEMBL8226;N-(2-CHLORO-6-METHYLPHENYL)-2-({6-[4-(2-HYDROXYETHYL)PIPERAZIN-1-YL]-2-METHYLPYRIMIDIN-4-YL}AMINO)-1,3-THIAZOLE-5-CARBOXAMIDE;n-(2-chloro-6-methylphenyl)-2-[[6-[4-(2-hydroxyethyl)-1-piperazinyl]-2-methyl-4-pyrimidinyl]amino]-5-thiazolecarboxamide;HMS3244A05;Q419940;D-3307;Pharmakon1600-01502275;HMS3244B05;HMS3654K05;NSC-759877;NCGC00181129-02;NSC-732517;AC-22749;BCB03_000715;NCGC00181129-07;5-Thiazolecarboxamide, monohydrate;Tox21_112736;dasatinib (anh.);HMS3744C11;2-(6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-ylamino)-N-(2-chloro-6-methylphenyl)thiazole-5-carboxamide;DASATINIB [INN];DB01254;NSC800087;PA-3062316;s1021;CHEMBL1421;CCG-264779;UNII-RBZ1571X5H;X78UG0A0RN;UNII-X78UG0A0RN;SMR002529551;GS-6548;Kinome_3650;NSC 759877;SR-00000000554;N-(2-Chloro-6-methylphenyl)-2-[[6-[4-(2-hydroxyethyl)-1-piperazinyl)]-2-methyl-4-pyrimidinyl]amino)]-1,3-thiazole-5-carboxamide;NCGC00481571-01;Tox21_112736_1;AB01273956-02;1N1;NCGC00181129-06;HMS3265C20;Sprycel;MLS004774145;Sprycel (Bristol Meyers);NCGC00181129-05;AB01273956_03;HMS3265D20;Dasatinib [USAN:INN];L01XE06;n-(2-chloro-6-methylphenyl)-2-((6-(4-(2-hydroxyethyl)pipe... |
| CAS号: | 302962-49-8 |
| 分子式: | C22H26CLN7O2S |
| 分子量: | 488.01 |
| 密度: | |
| 熔点: | |
| 沸点: | |
| 闪点: | |
| 水溶性: | |
| 蒸气压: |
达沙替尼
英文名:
Dasatinib
别名:达沙替尼;N-(2-氯-6-甲基苯基)-2-[[6-[4-(2-羟乙基)哌嗪-1-基]-2-甲基嘧啶-4-基]氨基]-1,3-噻唑-5-甲酰胺;达沙替尼及其中间体;达沙替尼(无水);达沙替尼,Dasatinib;达沙替尼API;达沙替尼-D8;达沙替尼标准品;达沙替尼无水物;达沙替尼杂质;美喹他嗪;5-噻唑甲酰胺,N-(2-氯-6-甲基苯基)-2-[[6-[4-(2-羟基乙基)-1-哌嗪基]-2-甲基-4-嘧啶基]氨基];DASA锡IB;达沙替尼(无水)(对照品)
商品编号:R009014-5g
规格:5g
纯度:98%
CAS号: 302962-49-8
分子式:C22H26CLN7O2S
分子量:488.01
| 价格 |
¥ 329.00
(请 登录 会员查看折扣价)
|
| 货期 | 现货 |
数量
搜索质检报告(COA)
搜索MSDS
相关产品


















